StockTipsArenaBeta

BUY Gland Pharma Limited — ICICI Securities

BUYGland Pharma Limited
Gland Pharma share price target & all analyst calls

byICICI SecuritiesHorizon: NA (inferred 1–3 months)7 Sept 2026via Economic Times New Stock Recos

Entry₹2,940Inferred
Target₹3,220
Total upside +9.52%
Stop lossNot given
CMP₹2,826.82d ago
Active-3.85%+13.91%upside left 6 wk left
Follow ICICI Securities for new callsGet alertsWatch GLAND for new buy/sell callsGet alertsSee 2 other Short-term calls on GLAND

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 26 Oct, 12:03 am IST
22 supporting10 neutral4 opposing
Supports the BUY call (22)

MACD above its signal line — bullish momentum

Technicals · macd·25 Oct · today

2 other SEBI-registered advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·13 Oct · 2w ago

5 advisors have active long-term BUY calls on this stock

Advisor consensus · adjacent horizon·7 Oct · 3w ago

Gland Pharma sets e-voting for Wang appointment; $21m US investment approved

NewsGoogle News·6 Oct · 3w ago

(opens in new tab)

Gland Pharma to invest $21 million in US drugmaker, take 60% stake

NewsCnbc-Tv18·1 Oct · 3w ago

(opens in new tab)
Neutral / worth noting (10)

Q2 FY27 results scheduled — board meets 06 Nov 2026

BSE · Board Meeting·In 11 days

(opens in new tab)
Weighs against the BUY call (4)

2 advisors have active long-term SELL calls on this stock

Advisor consensus · adjacent horizon·12 Aug · 2mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Gland Pharma

All analyst calls on Gland Pharma

More from ICICI Securities

Every call and its outcome